{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "457",
                "467"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zamkni\u0119ciu"
        },
        {
            "identifier": "T2",
            "position": [
                "498",
                "509"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "16.07.2018r"
        },
        {
            "identifier": "T3",
            "position": [
                "631",
                "643"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Hydroxyzinum"
        },
        {
            "identifier": "T4",
            "position": [
                "777",
                "780"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "PDA"
        },
        {
            "identifier": "T5",
            "position": [
                "795",
                "812"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badania kontrolne"
        },
        {
            "identifier": "T6",
            "position": [
                "815",
                "832"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergiczny"
        },
        {
            "identifier": "T7",
            "position": [
                "833",
                "839"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "ujemny"
        },
        {
            "identifier": "T8",
            "position": [
                "468",
                "496"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "dro\u017cnego przewodu t\u0119tniczego"
        },
        {
            "identifier": "T9",
            "position": [
                "842",
                "856"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T10",
            "position": [
                "857",
                "870"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "icd": "ICD10:Z95.8",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Obecno\u00c5\u009b\u00c4\u0087 innych implant\u00c3\u00b3w i przeszczep\u00c3\u00b3w sercowo-naczyniowych"
        },
        {
            "icd": "ICD10:Q25.0",
            "identifier": "N2",
            "referenced": "T4",
            "subtype": "Reference",
            "type": "N",
            "value": "Dro\u00c5\u00bcny przew\u00c3\u00b3d t\u00c4\u0099tniczy"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N3",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "icd": "ICD10:Q25.0",
            "identifier": "N4",
            "referenced": "T8",
            "subtype": "Reference",
            "type": "N",
            "value": "Dro\u00c5\u00bcny przew\u00c3\u00b3d t\u00c4\u0099tniczy"
        },
        {
            "arg1": "T2",
            "arg2": "T8",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T10",
            "arg2": "T9",
            "identifier": "R12",
            "subtype": "Neg",
            "type": "R"
        },
        {
            "arg1": "T2",
            "arg2": "T1",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T7",
            "arg2": "T6",
            "identifier": "R4",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q25.0|Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Stan po zamkni\u0119ciu dro\u017cnego przewodu t\u0119tniczego (16.07.2018r.)\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nHydroxyzinum\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\ndziecko zPDA skierowane na badania kontrolne , wywiad alergiczny ujemny , lek\u00f3w na sta\u0142e nie otrzymuje\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nGrupa krwi + p/c odporno\u015bciowe (powy\u017cej 4. m-ca \u017cycia\n    NR-KS:G-19/003621\n    KODKRESKOWYPROBKI:G-19/003621\n    GR:O\n    RH:+ (dodatni)\n    FENOTYP:K+\n    P-CIALA:Przeciwcia\u0142 odporno\u015bciowych dla antygen\u00f3w krwinek czerwonych nie stwierdzono.\nMorfologia krwi + PLT rozdzia\u0142 5 cz\u0119\u015b\u0107 WBC\n    WBC Krwinki bia\u0142e:8.40[10^3/ul]\n    RBC Krwinki czerwone:4.79[10^6/ul]\n    HGB Hemoglobina:13.1[g/dl]\n    HCT Hematokryt:37.6[%]\n    MCV wska\u017anik czerwonokrw:78.5[fl]\n    MCH wska\u017anik czerwonokrw:27.3[pg]\n    MCHC wska\u017anik czerwonokr:34.8[g/dl]\n    PLT z morfologii:335[10^3/ul]\n    RDW-SD:34.6[fl]\n    RDW-CV:12.1[%]\n    PDW:12.8[fl]\n    MPV:10.7[fl]\n    P-LCR:30.4[%]\n    PCT (hematokryt p\u0142ytkowy:0.36[%]\n    NEUTR# warto\u015b\u0107 bezwzgl\u0119d:2.12[10^3/ul]\n    NEUTR%:25.3[%]\n    LYMH# warto\u015b\u0107 bezwzgl\u0119dn:5.22[10^3/ul]\n    LYMPH%:62.1[%]\n    MONO# warto\u015b\u0107 bezwzgl\u0119dn:0.66[10^3/ul]\n    MONO%:7.9[%]\n    EO# warto\u015b\u0107 bezwzgl\u0119dna:0.34[10^3/ul]\n    EO%:4.0[%]\n    BASO# warto\u015b\u0107 bezwzgl\u0119dn:0.06[10^3/ul]\n    BASO%:0.7[%]\n    NRBC %:0.1[%]\n    NRBC #:0.01[10^3/ul]\nAntytrombina III: Antytrombina III:105[%]\nCzas kaolinowo-kefalinowy (APTT): APTT-SP:35.4[sek]\nCzas protrombinowy (PT)\n    Czas protrombinowy:12.1[sek]\n    Wska\u017anik PT:90.9[%]\n    INR:1.10\nCzas trombinowy TT: Czas trombinowy TT:16.9[sek]\nFibrynogen: Fibrynogen:1.79[g/L]\nALAT: ALAT:15[U/L]\nASPAT: ASPAT:46[U/L]\nCRP Bia\u0142ko C-reaktywne\n    CRP Bia\u0142ko C-reaktywne:\n    0.50[mg/dl]\nS\u00f3d (Na): S\u00f3d:141[mmol/L]\nPotas (K): Potas:5.1[mmol/L]\nChlorki (Cl): Chlorki:105[mmol/L]\nKreatynina + GFR\n    Kreatynina w surowicy:0.28[mg/dl]\n    eGFR stand. wg Schwartza:172.9[ml/min/1,73 m^2]\n    wzrost:88[cm]\nMleczany (LAC): Mleczany:22.4[mg/dl]\nMagnez: Magnez:0.79[mmol/L]\nMocznik: Mocznik:20[mg/dl]\nWap\u0144 ca\u0142kowity: Wap\u0144 ca\u0142kowity:2.56[mmol/L]\nR\u00f3wnowaga Kwasowo-Zasadowa (RKZ)\n    pH:7.366\n    pCO2:41.7[mmHg]\n    BE:-1.50[mmol/L]\n    HCO3:23.3[mmol/L]\n    pO2:34.5[mmHg]\n    O2Sat:62.6[%]\nGlukoza w surowicy: Glukoza w surowicy:79[mg/dl]\nNT-proBNP surowica: NT-proBNP w surowicy:119[pg/ml]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ25.0\nZ95.8\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n------------------------------------------------"
}